Skin Sensitivity Can ID Responders to Galcanezumab for Migraine Prevention; Findings seen for both chronic migraine and high-frequency episodic migraine patients based on pain-free state.

  • Sait Ashina

Press/Media

Period21 Feb 2023

Media coverage

1

Media coverage

  • TitleSkin Sensitivity Can ID Responders to Galcanezumab for Migraine Prevention; Findings seen for both chronic migraine and high-frequency episodic migraine patients based on pain-free state.
    Media name/outletPhysician's Briefings
    Country/TerritoryUnited States
    Date21/02/23
    PersonsSait Ashina
View all 1
View less